Abstract
Lack of safety data on pregnant women determines difficulty in choosing the correct biologic agent to treat psoriasis in women of childbearing potential. Studies have postulated a role of IL‐23 in unexplained recurrent spontaneous abortions. This gives rise to consideration about use of anti‐IL‐23 drugs in treatment of psoriasis in women of childbearing potential.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have